Related references
Note: Only part of the references are listed.Dendritic cells in cancer immunology and immunotherapy
Stefanie K. Wculek et al.
NATURE REVIEWS IMMUNOLOGY (2020)
Unleashing Type-2 Dendritic Cells to Drive Protective Antitumor CD4+ T Cell Immunity
Mikhail Binnewies et al.
CELL (2019)
Systemic clinical tumor regressions and potentiation of PD1 blockade with in situ vaccination
Linda Hammerich et al.
NATURE MEDICINE (2019)
β-Catenin Activation Promotes Immune Escape and Resistance to Anti-PD-1 Therapy in Hepatocellular Carcinoma
Marina Ruiz de Galarreta et al.
CANCER DISCOVERY (2019)
NK Cells Stimulate Recruitment of cDC1 into the Tumor Microenvironment Promoting Cancer Immune Control
Jan P. Boettcher et al.
CELL (2018)
A natural killer-dendritic cell axis defines checkpoint therapy-responsive tumor microenvironments
Kevin C. Barry et al.
NATURE MEDICINE (2018)
Successful Anti-PD-1 Cancer Immunotherapy Requires T Cell-Dendritic Cell Crosstalk Involving the Cytokines IFN-γ and IL-12
Christopher S. Garris et al.
IMMUNITY (2018)
WDFY4 is required for cross-presentation in response to viral and tumor antigens
Derek J. Theisen et al.
SCIENCE (2018)
DNGR-1 in dendritic cells limits tissue damage by dampening neutrophil recruitment
Carlos del Fresno et al.
SCIENCE (2018)
Critical role for Sec22b-dependent antigen cross-presentation in antitumor immunity
Andres Alloatti et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2017)
Enhanced anti-tumour immunity requires the interplay between resident and circulating memory CD8+ T cells
Michel Enamorado et al.
NATURE COMMUNICATIONS (2017)
Trial watch: Immunogenic cell death induction by anticancer chemotherapeutics
Abhishek D. Garg et al.
ONCOIMMUNOLOGY (2017)
Tumor-Residing Batf3 Dendritic Cells Are Required for Effector T Cell Trafficking and Adoptive T Cell Therapy
Stefani Spranger et al.
CANCER CELL (2017)
Resident memory T cells in the skin mediate durable immunity to melanoma
Brian T. Malik et al.
SCIENCE IMMUNOLOGY (2017)
Cancer Immunotherapy with Immunomodulatory Anti-CD137 and Anti-PD-1 Monoclonal Antibodies Requires BATF3-Dependent Dendritic Cells
Alfonso R. Sanchez-Paulete et al.
CANCER DISCOVERY (2016)
Critical Role for CD103+/CD141+ Dendritic Cells Bearing CCR7 for Tumor Antigen Trafficking and Priming of T Cell Immunity in Melanoma
Edward W. Roberts et al.
CANCER CELL (2016)
Tumoral Immune Cell Exploitation in Colorectal Cancer Metastases Can Be Targeted Effectively by Anti-CCR5 Therapy in Cancer Patients
Niels Halama et al.
CANCER CELL (2016)
Optimal Generation of Tissue-Resident but Not Circulating Memory T Cells during Viral Infection Requires Crosspriming by DNGR-1+ Dendritic Cells
Salvador Iborra et al.
IMMUNITY (2016)
Leishmania Uses Mincle to Target an Inhibitory ITAM Signaling Pathway in Dendritic Cells that Dampens Adaptive Immunity to Infection
Salvador Iborra et al.
IMMUNITY (2016)
Expansion and Activation of CD103+ Dendritic Cell Progenitors at the Tumor Site Enhances Tumor Responses to Therapeutic PD-L1 and BRAF Inhibition
Helene Salmon et al.
IMMUNITY (2016)
Density of immunogenic antigens does not explain the presence or absence of the T-cell-inflamed tumor microenvironment in melanoma
Stefani Spranger et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Cyclooxygenase-Dependent Tumor Growth through Evasion of Immunity
Santiago Zelenay et al.
CELL (2015)
Melanoma-intrinsic β-catenin signalling prevents anti-tumour immunity
Stefani Spranger et al.
NATURE (2015)
Batf3-dependent CD103(+) dendritic cells are major producers of IL-12 that drive local Th1 immunity against Leishmania major infection in mice
Maria Martinez-Lopez et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2015)
Macrophage IL-10 Blocks CD8+ T Cell-Dependent Responses to Chemotherapy by Suppressing IL-12 Expression in Intratumoral Dendritic Cells
Brian Ruffell et al.
CANCER CELL (2014)
Dissecting the Tumor Myeloid Compartment Reveals Rare Activating Antigen-Presenting Cells Critical for T Cell Immunity
Miranda L. Broz et al.
CANCER CELL (2014)
Shifting FcγRIIA-ITAM from activation to inhibitory configuration ameliorates arthritis
Sanae Ben Mkaddem et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
Classical Flt3L-dependent dendritic cells control immunity to protein vaccine
Niroshana Anandasabapathy et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2014)
Genetic Tracing via DNGR-1 Expression History Defines Dendritic Cells as a Hematopoietic Lineage
Barbara U. Schraml et al.
CELL (2013)
The Cancer Genome Atlas Pan-Cancer analysis project
John N. Weinstein et al.
NATURE GENETICS (2013)
Maraviroc, a CCR5 Antagonist, Prevents Development of Hepatocellular Carcinoma in a Mouse Model
Laura Ochoa-Callejero et al.
PLOS ONE (2013)
Tumor Necrosis Is a Prognostic Factor in Thick Cutaneous Melanoma
Rita Grude Ladstein et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2012)
F-Actin Is an Evolutionarily Conserved Damage-Associated Molecular Pattern Recognized by DNGR-1, a Receptor for Dead Cells
Susan Ahrens et al.
IMMUNITY (2012)
The Dendritic Cell Receptor Clec9A Binds Damaged Cells via Exposed Actin Filaments
Jian-Guo Zhang et al.
IMMUNITY (2012)
The dendritic cell receptor DNGR-1 controls endocytic handling of necrotic cell antigens to favor cross-priming of CTLs in virus-infected mice
Santiago Zelenay et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
Deciphering the transcriptional network of the dendritic cell lineage
Jennifer C. Miller et al.
NATURE IMMUNOLOGY (2012)
Cross-dressed CD8α+/CD103+ dendritic cells prime CD8+ T cells following vaccination
Lijin Li et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Characterization of human DNGR-1+ BDCA3+ leukocytes as putative equivalents of mouse CD8α+ dendritic cells
Lionel Franz Poulin et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2010)
The concerted action of GM-CSF and Flt3-ligand on in vivo dendritic cell homeostasis
Dior Kingston et al.
BLOOD (2009)
The Small GTPase Rac2 Controls Phagosomal Alkalinization and Antigen Crosspresentation Selectively in CD8+ Dendritic Cells
Ariel Savina et al.
IMMUNITY (2009)
The origin and development of nonlymphoid tissue CD103+ DCs
Florent Ginhoux et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2009)
Identification of a dendritic cell receptor that couples sensing of necrosis to immunity
David Sancho et al.
NATURE (2009)
CLEC9A is a novel activation C-type lectin-like receptor expressed on BDCA3+ dendritic cells and a subset of monocytes
Cristal Huysamen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Tumor therapy in mice via antigen targeting to a novel, DC-restricted C-type lectin
David Sancho et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
Batf3 Deficiency Reveals a Critical Role for CD8α+ Dendritic Cells in Cytotoxic T Cell Immunity
Kai Hildner et al.
SCIENCE (2008)
Efficacy of short-term monotherapy with maraviroc, a new CCR5 antagonist, in patients infected with HIV-1
G Fätkenheuer et al.
NATURE MEDICINE (2005)
Altered peptide ligand vaccination with Flt3 ligand expanded dendritic cells for tumor immunotherapy
L Fong et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Share Paper
